Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasco da Gama azithromycin continuation versus withdrawal in stable COPD
NL-OMON24560Not yet recruiting
- Sponsor
- Eurocept Groep
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in chronic obstructive pulmonary disease (COPD) comparing Continuation of azithromycin maintenance with Withdrawal of azithromycin with placebo control (2 arms). Primary endpoint: Time to first COPD exacerbation. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON24560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24560.